Fulgent Genetics, Inc. (FLGT) vs GeneDx Holdings Corp. (WGS)
- Fulgent Genetics, Inc. FLGT 19.81 −7.17%
- GeneDx Holdings Corp. WGS 63.60 −9.43%
Fulgent Genetics, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. GeneDx Holdings Corp. is the larger, with a market value of $2.1B against $587.2M — 3.6× the size. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against 6.83%. GeneDx Holdings Corp. has the higher net margin (−23.4% vs −26.1%) and the lower return on invested capital (−27.7% vs −10.3%). Across the 18 metrics below, GeneDx Holdings Corp. leads on 10 and Fulgent Genetics, Inc. on 8.
Valuation
Profitability
| Metric | FLGT | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 35.58% | 69.37% | 50.89% |
| Operating margin | (37.75%) | (20.34%) | (8.57%) |
| Net margin | (26.05%) | (23.40%) | (6.37%) |
| Free cash flow margin | (32.04%) | (16.68%) | 0.00% |
| Return on equity | (8.01%) | (40.80%) | (2.92%) |
| Return on assets | (7.37%) | (22.50%) | (6.71%) |
| Return on invested capital | (10.34%) | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack